Today was a good day for personalized medicine with the report in the NEJM on treating breast cancer. A study looked at women categorized by a 21-gene assay [1] that predicted recurrence and whose care was predicated upon those findings.
Coverage of infectious and chronic diseases — their causes, mechanisms, epidemiology, prevention strategies, and the latest science on how the body fights back.
